111 related articles for article (PubMed ID: 17372244)
1. Validity of self-reports of return for routine repeat screening in an ovarian cancer screening program.
Lykins EL; Pavlik EL; Andrykowski MA
Cancer Epidemiol Biomarkers Prev; 2007 Mar; 16(3):490-3. PubMed ID: 17372244
[TBL] [Abstract][Full Text] [Related]
2. Factors associated with return for routine annual screening in an ovarian cancer screening program.
Andrykowski MA; Zhang M; Pavlik EJ; Kryscio RJ
Gynecol Oncol; 2007 Mar; 104(3):695-701. PubMed ID: 17145075
[TBL] [Abstract][Full Text] [Related]
3. The efficacy of transvaginal sonographic screening in asymptomatic women at risk for ovarian cancer.
van Nagell JR; DePriest PD; Reedy MB; Gallion HH; Ueland FR; Pavlik EJ; Kryscio RJ
Gynecol Oncol; 2000 Jun; 77(3):350-6. PubMed ID: 10831341
[TBL] [Abstract][Full Text] [Related]
4. Compliance of average- and intermediate-risk women to semiannual ovarian cancer screening.
Drescher CW; Nelson J; Peacock S; Andersen MR; McIntosh MW; Urban N
Cancer Epidemiol Biomarkers Prev; 2004 Apr; 13(4):600-6. PubMed ID: 15066925
[TBL] [Abstract][Full Text] [Related]
5. Transvaginal sonography as a screening method for the detection of early ovarian cancer.
DePriest PD; Gallion HH; Pavlik EJ; Kryscio RJ; van Nagell JR
Gynecol Oncol; 1997 Jun; 65(3):408-14. PubMed ID: 9190966
[TBL] [Abstract][Full Text] [Related]
6. Ovarian cancer screening with annual transvaginal sonography: findings of 25,000 women screened.
van Nagell JR; DePriest PD; Ueland FR; DeSimone CP; Cooper AL; McDonald JM; Pavlik EJ; Kryscio RJ
Cancer; 2007 May; 109(9):1887-96. PubMed ID: 17373668
[TBL] [Abstract][Full Text] [Related]
7. Ultrasound screening for the early detection of ovarian cancer.
DePriest PD; DeSimone CP
J Clin Oncol; 2003 May; 21(10 Suppl):194s-199s. PubMed ID: 12743134
[TBL] [Abstract][Full Text] [Related]
8. Ovarian cancer screening in asymptomatic postmenopausal women.
DePriest PD; van Nagell JR; Gallion HH; Shenson D; Hunter JE; Andrews SJ; Powell DE; Pavlik EJ
Gynecol Oncol; 1993 Nov; 51(2):205-9. PubMed ID: 8276295
[TBL] [Abstract][Full Text] [Related]
9. Psychological response to test results in an ovarian cancer screening program: a prospective, longitudinal study.
Andrykowski MA; Boerner LM; Salsman JM; Pavlik E
Health Psychol; 2004 Nov; 23(6):622-30. PubMed ID: 15546230
[TBL] [Abstract][Full Text] [Related]
10. Participation in transvaginal ovarian cancer screening: compliance, correlation factors, and costs.
Pavlik EJ; van Nagell JR; DePriest PD; Wheeler L; Tatman JM; Boone M; Sollars S; Rayens MK; Kryscio RK
Gynecol Oncol; 1995 Jun; 57(3):395-400. PubMed ID: 7774844
[TBL] [Abstract][Full Text] [Related]
11. [Program for early detection of ovarian cancer for women as prophylaxis provided at a municipal hospital].
Cnota W; Sodowski K; Olesiak-Andryszczak M; Pilch-Kowalczyk M
Wiad Lek; 2004; 57 Suppl 1():43-7. PubMed ID: 15884203
[TBL] [Abstract][Full Text] [Related]
12. Ovarian cancer screening.
van Nagell JR; Gallion HH; Pavlik EJ; DePriest PD
Cancer; 1995 Nov; 76(10 Suppl):2086-91. PubMed ID: 8635005
[TBL] [Abstract][Full Text] [Related]
13. Psychological impact of screening for familial ovarian cancer.
Wardle FJ; Collins W; Pernet AL; Whitehead MI; Bourne TH; Campbell S
J Natl Cancer Inst; 1993 Apr; 85(8):653-7. PubMed ID: 8468723
[TBL] [Abstract][Full Text] [Related]
14. How to decrease false-positive cases of ovarian cancer screening by transvaginal sonography.
Misawa T; Asai M; Higashide K
J Exp Clin Cancer Res; 1997 Jun; 16(2):217-20. PubMed ID: 9261750
[TBL] [Abstract][Full Text] [Related]
15. Psychological and behavioral impact of receipt of a "normal" ovarian cancer screening test.
Gaugler JE; Pavlik E; Salsman JM; Andrykowski MA
Prev Med; 2006 Jun; 42(6):463-70. PubMed ID: 16563482
[TBL] [Abstract][Full Text] [Related]
16. The efficacy of a sonographic morphology index in identifying ovarian cancer: a multi-institutional investigation.
DePriest PD; Varner E; Powell J; Fried A; Puls L; Higgins R; Shenson D; Kryscio R; Hunter JE; Andrews SJ
Gynecol Oncol; 1994 Nov; 55(2):174-8. PubMed ID: 7959280
[TBL] [Abstract][Full Text] [Related]
17. Continuing participation supports ultrasound screening for ovarian cancer.
Pavlik EJ; Johnson TL; Depriest PD; Andrykowski MA; Kryscio RJ; Van Nagell JR
Ultrasound Obstet Gynecol; 2000 May; 15(5):354-64. PubMed ID: 10976474
[TBL] [Abstract][Full Text] [Related]
18. Clinical, demographic, and psychological characteristics of new, asymptomatic participants in a transvaginal ultrasound screening program for ovarian cancer.
Salsman JM; Pavlik E; Boerner LM; Andrykowski MA
Prev Med; 2004 Aug; 39(2):315-22. PubMed ID: 15226040
[TBL] [Abstract][Full Text] [Related]
19. Three-dimensional ultrasonography and power Doppler in ovarian cancer screening of asymptomatic peri- and postmenopausal women.
Kurjak A; Prka M; Arenas JM; Sparac V; Merce LT; Corusic A; Ivancic-Kosuta M
Croat Med J; 2005 Oct; 46(5):757-64. PubMed ID: 16158468
[TBL] [Abstract][Full Text] [Related]
20. Ovarian cancer screening.
van Nagell JR; DePriest PD; Gallion HH; Pavlik EJ
Cancer; 1993 Feb; 71(4 Suppl):1523-8. PubMed ID: 8431889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
